Search

everythinglearnresearchcommunity

for

Search:↓

Men with low testosterone should be carefully evaluated and monitored before and during treatment.

Topical finasteride doesn't reduce DHT levels, hinting at an endocrine role in hair loss.

Spironolactone reduces the number of androgen receptor sites in rat skin by blocking them with its metabolite.

Human keratinocytes do not naturally respond to androgens.

Treatments for common hair loss include minoxidil, finasteride, and hair transplantation.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

A 31-year-old woman was diagnosed with Complete Androgen Insensitivity Syndrome much later than usual, leading to a call for earlier detection and treatment guidelines.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.

Personalized treatments for hair loss are becoming more effective by using genetic information.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

A specific pathway involving AR, miR-221, and IGF-1 plays a key role in causing common hair loss.

A new hair loss treatment using dissolving microneedles was found to speed up hair growth and was more effective than daily use of common hair growth drugs.

New acne treatments like clascoterone and minocycline foam are effective, and using antibiotics carefully is important to avoid resistance.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Androgens can both promote and prevent hair growth due to differences in gene expression in hair follicles.

A new gene, JMJD1C, may affect testosterone levels in men.

Gender-affirming hormone therapy affects metabolism differently based on treatment type.

Bilateral Orchiectomy effectively reduces the need for anti-androgen medication in most transgender females.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

A young woman's symptoms suggested PCOS, but tests and surgery confirmed and treated a rare ovarian tumor, resolving her condition.

Hirsutism in women often indicates health issues like polycystic ovarian syndrome and is treated with lifestyle changes, medication, and cosmetic measures.

The study found that imaging might miss small ovarian tumors causing high testosterone, and suggested using certain testosterone levels and treatment responses to identify these tumors.

Overweight women with PCOS are more likely to have excess male hormones.

Excess androgens may cause PCOS, not just be a symptom.

A young woman had a rare tumor causing high male hormone levels and symptoms like excessive hair and acne. After removing the tumor, her hormone levels returned to normal. Early diagnosis is important.

Too much male hormone in mothers can negatively affect the sexual behavior of both male and female baby mice.

PCOS is diagnosed when at least two of these three features are present: polycystic ovaries, irregular ovulation, and high androgen levels.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.